USE OF BACTEROIDES FRAGILIS IN IMPROVEMENT AND TREATMENT OF DIARRHEA
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 27, 2025
app pub date -
Dec 29, 2022
filing date -
Dec 29, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Provided is the use of Bacteroides fragilis in the improvement and/or treatment of diarrhea. Tests of different mouse diarrhea models prove that Bacteroides fragilis ZY-312 with the deposit number CGMCC No. 10685 or inactivated Bacteroides fragilis ZY-312 has the effect of improving and treating diarrhea. The powder of the inactivated Bacteroides fragilis has a good effect of improving infectious diarrhea or non-infectious diarrhea in different concentrations of the formula, and has no side effects on the body.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully